These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2644877

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Nifedipine in the treatment of Raynaud's syndrome.
    Aldoori M, Campbell WB, Dieppe PA.
    Cardiovasc Res; 1986 Jun; 20(6):466-70. PubMed ID: 3536108
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
    Vayssairat M, Blaison N, Baudot N, Evenou P, Gilard M, Mathieu JF.
    J Mal Vasc; 1989 Jun; 14(4):299-302. PubMed ID: 2584886
    [Abstract] [Full Text] [Related]

  • 28. Nifedipine as a therapeutic modality for Raynaud's phenomenon.
    Winston EL, Pariser KM, Miller KB, Salem DN, Creager MA.
    Arthritis Rheum; 1983 Oct; 26(10):1177-80. PubMed ID: 6626276
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
    Wise RA, Malamet R, Wigley FM.
    J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Use of nifedipine in patients with Raynaud's phenomenon].
    Rozwodowska M, Polaszewska-Muszyńska M, Ukleja-Adamowicz M, Rewakowicz M, Guzowska M, Marunowska A, Jundziłł W, Wodyńska T, Ruchalski M, Strzelecki A.
    Kardiol Pol; 1987 Apr; 30 Suppl():97-105. PubMed ID: 3331405
    [No Abstract] [Full Text] [Related]

  • 35. Nifedipine in primary Raynaud's phenomenon and in scleroderma: oral versus sublingual hemodynamic effects.
    Wollersheim H, Thien T, van 't Laar A.
    J Clin Pharmacol; 1987 Nov; 27(11):907-13. PubMed ID: 3429697
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Nisoldipine in primary Raynaud's phenomenon.
    Challenor VF, Waller DG, Francis DA, Francis JL, Mani R, Roath S.
    Eur J Clin Pharmacol; 1987 Nov; 33(1):27-30. PubMed ID: 3691593
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Enalapril in Raynaud's phenomenon.
    Janini SD, Scott DG, Coppock JS, Bacon PA, Kendall MJ.
    J Clin Pharm Ther; 1988 Apr; 13(2):145-50. PubMed ID: 2839529
    [Abstract] [Full Text] [Related]

  • 40. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases.
    Kahan A, Weber S, Amor B, Menkes CJ, Hodara M, Degeorges M.
    Int Angiol; 1985 Apr; 4(2):221-3. PubMed ID: 3831143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.